View More Recent Stories

Sep 16, 2024 07:02AM Nuvalent (NUVL) Announces Public Offering of Common Stock
Sep 13, 2024 09:54AM Nuvalent Inc (NUVL) Announces Publication in Cancer Discovery Detailing Design and Characterization of NVL-655
Sep 10, 2024 06:33AM Baird Reiterates Outperform Rating on Nuvalent (NUVL)
Sep 10, 2024 05:08AM Jefferies Reiterates Buy Rating on Nuvalent (NUVL)
Sep 9, 2024 11:57AM Piper Sandler Reiterates Overweight Rating on Nuvalent (NUVL)
Sep 9, 2024 06:31AM Nuvalent Inc (NUVL) Reports Latest Data on NVL-655
Sep 6, 2024 11:49AM Barclays Reiterates Overweight Rating on Nuvalent (NUVL), PT $100
Aug 30, 2024 07:06AM Piper Sandler Reiterates Overweight Rating on Nuvalent (NUVL)
Aug 29, 2024 03:42AM Barclays Starts Nuvalent (NUVL) at Overweight
Aug 8, 2024 06:35AM Nuvalent, Inc. (NUVL) Misses Q2 EPS by 12c
Jul 11, 2024 06:30AM Nuvalent Inc (NUVL) Appoints Henry Pelish as Chief Scientific Officer
Jul 9, 2024 04:09PM Nuvalent (NUVL) PT Raised to $115 at Stifel
View More Recent Stories